These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2581118)

  • 1. Theoretical mechanisms for synthesis of carcinogen-induced embryonic proteins: XIII. Mutational and non-mutational mechanisms as subsets of a more general mechanism. Part B--hereditary tyrosinemia.
    Hancock RL
    Med Hypotheses; 1985 Feb; 16(2):183-7. PubMed ID: 2581118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theoretical mechanisms for synthesis of carcinogen-induced embryonic proteins: XII mutational and non-mutational mechanism as subsets of a more general mechanism. Part A--Ethionine.
    Hancock RL
    Med Hypotheses; 1984 Nov; 15(3):323-31. PubMed ID: 6084164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A specific mechanism for ethionine-induced embryonic gene activity.
    Hancock RL
    Med Hypotheses; 1993 May; 40(5):284-6. PubMed ID: 7688849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theoretical mechanisms for synthesis of carcinogen-induced embryonic proteins. I. Alpha-fetoprotein induction by ethionine.
    Forrester PI; Hancock RL
    Med Hypotheses; 1978; 4(1):31-6. PubMed ID: 76285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theoretical mechanisms for synthesis of carcinogen-induced embryonic proteins: XVII. Heterochromatin mechanisms.
    Hancock RL
    Med Hypotheses; 1987 Aug; 23(4):363-9. PubMed ID: 2443818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theoretical mechanisms for synthesis of carcinogen-induced embryonic proteins: XIV. Mutational and non-mutational mechanisms as subsets of a more general mechanism. Part C. A defined cancer mutation.
    Hancock RL
    Med Hypotheses; 1985 Nov; 18(3):199-206. PubMed ID: 3853079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical studies on the enzymatic deficiencies in hereditary tyrosinemia.
    Berger R; van Faassen H; Smith GP
    Clin Chim Acta; 1983 Oct; 134(1-2):129-41. PubMed ID: 6652907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgical excision of a hepatoma complicating chronic tyrosinemia (author's transl)].
    Costil J; Taïeb B; Buffe D; Garel L; Boccon-Gibod L; Gruner M; Brissaud HE
    Arch Fr Pediatr; 1980 Mar; 37(3):187-90. PubMed ID: 6258535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for liver disease preceding amino acid abnormalities in hereditary tyrosinemia.
    Hostetter MK; Levy HL; Winter HS; Knight GJ; Haddow JE
    N Engl J Med; 1983 May; 308(21):1265-7. PubMed ID: 6188953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolution of the clinical features of tyrosinemia following orthotopic liver transplantation for hepatoma.
    Van Thiel DH; Gartner LM; Thorp FK; Newman SL; Lindahl JA; Stoner E; New MI; Starzl TE
    J Hepatol; 1986; 3(1):42-8. PubMed ID: 3018074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of oncofetal markers CA 125, CA 19-9, and alpha-fetoprotein in children with hereditary tyrosinemia type I.
    Pitkänen S; Salo MK; Kuusela P; Holmberg C; Simell O; Heikinheimo M
    Pediatr Res; 1994 Feb; 35(2):205-8. PubMed ID: 7513078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal instability in hereditary tyrosinemia type I.
    Gilbert-Barness E; Barness LA; Meisner LF
    Pediatr Pathol; 1990; 10(1-2):243-52. PubMed ID: 2156246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The occurrence of hepatoma in the chronic form of hereditary tyrosinemia.
    Weinberg AG; Mize CE; Worthen HG
    J Pediatr; 1976 Mar; 88(3):434-8. PubMed ID: 173827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hereditary tyrosinemia and alpha-1-fetoprotein. II. Comparative tissue levels of alpha-fetoprotein in 2 cases of hereditary tyrosinemia. Considerations on the ontogenesis of human fetoprotein].
    Bélanger L
    Pathol Biol (Paris); 1973 May; 21(5):457-63. PubMed ID: 4125221
    [No Abstract]   [Full Text] [Related]  

  • 15. Theoretical mechanisms for synthesis of carcinogen-induced embryonic proteins: XIX. Embryonic genes.
    Hancock RL
    Med Hypotheses; 1988 Jul; 26(3):177-82. PubMed ID: 2457144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable gene expression within human tyrosinemia type 1 liver may reflect region-specific dysplasia.
    Haber BA; Chuang E; Lee W; Taub R
    Hepatology; 1996 Jul; 24(1):65-71. PubMed ID: 8707285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single mutation of the fumarylacetoacetate hydrolase gene in French Canadians with hereditary tyrosinemia type I.
    Grompe M; St-Louis M; Demers SI; al-Dhalimy M; Leclerc B; Tanguay RM
    N Engl J Med; 1994 Aug; 331(6):353-7. PubMed ID: 8028615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theoretical mechanisms for synthesis of carcinogen-induced embryonic proteins: X. Correlation of the induceability of hepatomas and alpha-fetoprotein gene activity.
    Payette R; Hancock RL
    Med Hypotheses; 1982 Oct; 9(4):429-35. PubMed ID: 6185830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assay of fumarylacetoacetate fumarylhydrolase in human liver-deficient activity in a case of hereditary tyrosinemia.
    Kvittingen EA; Jellum E; Stokke O
    Clin Chim Acta; 1981 Sep; 115(3):311-9. PubMed ID: 7296877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six novel mutations in the fumarylacetoacetate hydrolase gene of patients with hereditary tyrosinemia type I.
    Timmers C; Grompe M
    Hum Mutat; 1996; 7(4):367-9. PubMed ID: 8723690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.